Dimensional Fund Advisors
ORGS

Dimensional Fund Advisors’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Dimensional Fund Advisors’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,654
Closed -$23K – 3515
2023
Q2 		$23K Sell
1,654
-2,017
-55% -$23.9K ﹤0.01% 3447
2023
Q1 		$43.3K Buy
3,671
+30
+0.8% +$563 ﹤0.01% 3394
2022
Q4 		$71 Buy
3,641
+1,200
+49% +$20.4K ﹤0.01% 3362
2022
Q3 		$35K Sell
2,441
-541
-18% -$10.2K ﹤0.01% 3437
2022
Q2 		$72K Buy
2,982
+605
+25% +$16.8K ﹤0.01% 3365
2022
Q1 		$82K Sell
2,377
-20
-0.8% -$608 ﹤0.01% 3415
2021
Q4 		$69K Sell
2,397
-128
-5% -$5.01K ﹤0.01% 3464
2021
Q3 		$125K Buy
2,525
+610
+32% +$30.6K ﹤0.01% 3403
2021
Q2 		$97K Buy
1,915
+81
+4% +$4.08K ﹤0.01% 3412
2021
Q1 		$105K Buy
1,834
+771
+73% +$50.2K ﹤0.01% 3346
2020
Q4 		$48K Buy
1,063
+1
+0.1% +$48 ﹤0.01% 3318
2020
Q3 		$54K Buy
+1,062
New +$57.6K ﹤0.01% 3304

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Dimensional Fund Advisors's ORGS Position: Q3 2023 in Review

Dimensional Fund Advisors sold out of Orgenesis Inc. Common Stock (ORGS) in Q3 2023, closing a stake of 1,654 shares — an estimated $23K sold.

Dimensional Fund Advisors first reported a position in ORGS in Q3 2020 and held it in 12 quarters. The position peaked at $125K in Q3 2021. 20 funds tracked by Wall St. Rank hold ORGS as of Q3 2023.

  • Dimensional Fund Advisors reported no remaining Orgenesis Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,654 Orgenesis Inc. Common Stock shares in Q3 2023, an estimated $23K.
  • Dimensional Fund Advisors first reported a position in Orgenesis Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • Dimensional Fund Advisors's Orgenesis Inc. Common Stock position peaked at $125K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q3 2023.

Based on Dimensional Fund Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.